MSH|^~\&|NISTEHRAPP^2.16.840.1.113883.3.72.5.40.1^ISO|NISTEHRFAC^2.16.840.1.113883.3.72.5.40.2^ISO|NISTIISAPP^2.16.840.1.113883.3.72.5.40.3^ISO|NISTIISFAC^2.16.840.1.113883.3.72.5.40.4^ISO|20150625103328.757-0500||VXU^V04^VXU_V04|NIST-IZ-AD-8.1_Send_V04_Z22|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|NISTEHRFAC^^^^^NIST-AA-IZ-1&2.16.840.1.113883.3.72.5.40.9&ISO^XX^^^100-6482|NISTIISFAC^^^^^NIST-AA-IZ-1&2.16.840.1.113883.3.72.5.40.9&ISO^XX^^^100-3322
PID|1||77100^^^NIST-MPI-1&2.16.840.1.113883.3.72.5.40.5&ISO^MR||Broadway^Ashley^Jennifer^^^^L|Layton^^^^^^M|20150516|F||2054-5^African American^CDCREC|901 North 12th St^^Bozeman^MT^59715^USA^P||^PRN^PH^^^406^5552262|||||||||2186-5^Not Hispanic or Latino^CDCREC||N|1|||||N
PD1|||||||||||03^Reminder/recall - no calls^HL70215|N|20150625|||A|20150516|20150625
NK1|1|Broadway^Ellen^^^^^L|MTH^Mother^HL70063|901 North 12th St^^Bozeman^MT^59715^USA^P|^PRN^PH^^^406^5552262
ORC|RE|3881^NIST-AA-IZ-2^2.16.840.1.113883.3.72.5.40.10^ISO|13926^NIST-AA-IZ-2^2.16.840.1.113883.3.72.5.40.10^ISO|||||||7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1&2.16.840.1.113883.3.72.5.40.7&ISO^L^^^PRN||654^Thomas^Wilma^Elizabeth^^^^^NIST-PI-1&2.16.840.1.113883.3.72.5.40.7&ISO^L^^^MD|||||NISTEHRFAC^NISTEHRFacility^HL70362
RXA|0|1|20150625||58160-0820-01^ENGERIX-B^NDC|0.5|mL^mL^UCUM||00^New Record^NIP001|7824^Jackson^Lily^Suzanne^^^^^NIST-PI-1&2.16.840.1.113883.3.72.5.40.7&ISO^L^^^PRN|^^^NIST-Clinic-1&2.16.840.1.113883.3.72.5.40.12&ISO||||797397|20151203|SKB^GlaxoSmithKline^MVX|||CP|A
RXR|C28161^Intramuscular^NCIT|LT^Left Thigh^HL70163
OBX|1|CE|30963-3^Vaccine Funding Source^LN|1|PHC70^Private^CDCPHINVS||||||F|||20150625
OBX|2|CE|64994-7^Vaccine Funding Program Eligibility^LN|2|V01^Not VFC Eligible^HL70064||||||F|||20150625|||VXC40^per immunization^CDCPHINVS
OBX|3|CE|69764-9^Document Type^LN|3|253088698300005911181012^Hepatitis B VIS^cdcgs1vis||||||F|||20150625
OBX|4|DT|29769-7^Date Vis Presented^LN|3|20150625||||||F|||20150625
